# US 2013/0157305 A1 · Method and system for evaluation of grafts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157305 A1
- Document ID: US20130157305A1
- Status: Published application
- Kind: A1
- Application number: 13/766,833
- Filed: 2013-02-14
- Published: 2013-06-20
- Earliest claimed: 2010-08-17
- Assignees: Terumo Kabushiki Kaisha
- Inventors: Kenta SAKAMOTO
- Web page: https://patentgrep.com/patent/US20130157305A1

## CPC

- C12Q 1/04: Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)}
- A61K 35/34: Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44)
- C12N 5/0658: {Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts}
- G01N 33/5026: {on cell morphology}
- G01N 2800/245: Transplantation related diseases, e.g. graft versus host disease
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method and system for evaluating the competence for transplantation of a graft sample containing cells capable of multinucleation are provided. In one form, the method includes determining multinucleating ability as an indicator representing the capacity for multinucleation of the cells capable of multinucleation.

## Claims

### Claim 1

A method for evaluating the competence for transplantation of a graft sample containing cells capable of multinucleation, the method comprising:
determination of multinucleating ability as an indicator representing the capacity for multinucleation of the cells capable of multinucleation,
wherein the determination of the multinucleating ability comprises:
(i) a step of dissociating a portion of one or not less than two graft samples into individual cells;
(ii) a step of incubating the dissociated cells obtained in step (i); and
(iii) a step of detecting multinucleate cells in a cell culture obtained upon the incubation in step (ii), and
the thus determined multinucleating ability is compared with a preset threshold value.

### Claim 2 (depends on 1)

The method as defined in claim 1, wherein the cells capable of multinucleation are skeletal myoblasts.

### Claim 3 (depends on 1)

The method as defined in claim 1, wherein the multinucleating ability is rate of multinucleation.

### Claim 4 (depends on 1)

The method as defined in claim 1, wherein the graft sample is determined as competent for transplantation to a living body where the cells capable of multinucleation are skeletal myoblasts and the rate of multinucleation as the multinucleating ability to be determined is higher than a preset threshold value.

### Claim 5

A system for evaluation of competence for transplantation of a graft sample containing cells capable of multinucleation, the system comprising:
a detecting unit which detects multinucleate cells; and
a calculating unit which calculates the multinucleating ability.

### Claim 6 (depends on 5)

The system as defined in claim 5, wherein the detecting unit has an image analyzing unit which analyzes a cell image picked up.

### Claim 7 (depends on 6)

The system as defined in claim 6, wherein the image analyzing unit has an imaging unit which picks up an image of stained cells, and the analysis by the image analyzing unit includes distinguishing between a cell region and a cell nucleus region in the cell image picked up by the imaging unit.

### Claim 8

A method for evaluating the competence for transplantation of a graft sample containing cells capable of multinucleation, the method comprising:
determination of multinucleating ability as an indicator representing the capacity for multinucleation of the cells capable of multinucleation,
wherein the multinucleating ability is rate of multinucleation.

### Claim 9 (depends on 8)

The method as defined in claim 8, wherein the cells capable of multinucleation are skeletal myoblasts.

### Claim 10

A method for evaluating the competence for transplantation of a graft sample containing cells capable of multinucleation, the method comprising:
determination of multinucleating ability as an indicator representing the capacity for multinucleation of the cells capable of multinucleation,
wherein the graft sample is determined as competent for transplantation to a living body where the cells capable of multinucleation are skeletal myoblasts and the rate of multinucleation as the multinucleating ability to be determined is higher than a preset threshold value.

### Claim 11 (depends on 10)

The method as defined in claim 10, wherein the cells capable of multinucleation are skeletal myoblasts.

### Claim 12 (depends on 2)

The method as defined in claim 2, wherein the multinucleating ability is rate of multinucleation.

### Claim 13 (depends on 2)

The method as defined in claim 2, wherein the graft sample is determined as competent for transplantation to a living body where the cells capable of multinucleation are skeletal myoblasts and the rate of multinucleation as the multinucleating ability to be determined is higher than a preset threshold value.
